Covidien’s profits drop slightly in 1Q as sales rise 5%

MED-TECH MAKER COVIDIEN PLC saw its profits dip 0.2 percent during the first quarter of 2013 as its sales rose 5.45 percent to $3.06 billion.
Posted 1/25/13

MANSFIELD – Medical technology maker Covidien Plc reported first-quarter earnings of $493 million, or $1.03 per diluted share, a slight decrease from the $494 million, or $1.02 per diluted share, reported for the first-quarter of its fiscal 2012.

At the same time, the company’s sales rose 5.45 percent year over year to $3.06 billion during the three months ended Dec. 28, 2012.

“We’re off to a very good start in fiscal 2013, with first-quarter results exceeding our expectations,” José E. Almeida, president and CEO, said in a prepared statement.

“In our large medical devices segment, we continued to generate above-market growth in a number of key categories, including stapling, energy, airway and ventilation,” said Almeida. “We delivered very strong growth in emerging markets, as we realized the benefits of our recent substantial investments in these fast-growing regions.”

“We made significant progress reshaping our portfolio in 2012,” said Almeida. “We announced the spinoff of the pharmaceuticals business, while adding more than $4 billion in new market opportunities through acquisitions that offer excellent growth prospects.”

Year over year in the first quarter, the company’s medical device sales grew 4 percent in the U.S. and 11 percent in non-U.S. markets. Pharmaceutical division sales increased 3 percent during the first quarter of fiscal 2013 in the U.S., but dropped 7 percent in non-U.S. markets, and Covidien’s medical supplies segment revenue rose 3 percent in the U.S. and stayed stagnant outside the U.S. during the quarter.

“For the remainder of the year, we plan to make incremental growth-driving investments in R&D and SG&A that should enhance our future growth,” said Almeida. “We remain confident that our robust pipeline of new products, sizable expansion opportunities in emerging markets and promising portfolio additions will enable us to meet the significant challenges of the global marketplace and to continue to deliver good operational growth.”

PBN Hosted

Join PBN and two panels of successful female executives, business owners and entrepreneurs as we delve into what women should do to advance their careers, and become leaders in the corporate world and their own enterprises.
  • Book of Lists Party
    Save the date - January 15, 2015 for PBN's Book of Lists Party at the Providence ...
Purchase Data
Book of Lists
Book of Lists cover
PBN's annual Book of Lists has been an essential resource for the local business community for almost 30 years. The Book of Lists features a wealth of company rankings from a variety of fields and industries, including banking, health care, real estate, law, hospitality, education, not-for-profits, technology and many more.
Data icons
Data can be purchased as single lists, in either Excel or PDF format; the entire database of the published book, in Excel format; or a printed copy of the Book of Lists.
  • Purchase an e-File of a single list
  • Purchase an e-File of the entire Book of Lists database
  • Purchase a printed copy of the Book of Lists
    Latest News